PMC8645499_01
Brain magnetic resonance imaging (MRI) showed a cerebellar mass measuring 45 x 50 mm. The mass was hypointense on T1W sequence (a), hyper- and iso-intense on T2W sequence (b), and was heterogeneously enhanced on T1W postgadolinium (c).
SNI-12-549-g001.jpg
PMC8645499_01_SNI-12-549-g001.jpg
F1
Brain magnetic resonance imaging (MRI) showed a cerebellar mass measuring 45x50 millimeters [Figure 1].
The brain and spine MRI follow-ups showed no tumor remnant and metastasis at 1-year. 2-year, 3-year posttreatment.
SNI-12-549-g002.jpg
PMC8645499_01_SNI-12-549-g002.jpg
F2
The postoperative MRI of the brain and spine showed no tumor remnant and metastasis [Figure 2].
After a 4-year follow-up, brain computed tomography (a) illustrated a temporal mass, which was hyperdense on computed tomography. On MRI, it enhanced heterogeneously on T1W postgadolinium (b) and hyperintense on T2W sequence (c).
SNI-12-549-g003.jpg
PMC8645499_01_SNI-12-549-g003.jpg
F3
T1W sequence, hyperintense on T2W sequence, and enhanced heterogeneously on T1W postgadolinium [Figure 3]. The spine MRI showed no metastasis lesion.
The histopathological examination revealed germinoma. The immunohistochemistry staining was CD117 (+), PLAP (+), Ki67 (+), beta-hCG (-), AFP (-), LCA (-), S100 (-), Synaph (-), GFAP (-), and CK (-).
SNI-12-549-g004.jpg
PMC8645499_01_SNI-12-549-g004.jpg
F4
AFP (-), LCA (-), S100 (-), Synaph (-), GFAP (-), and CK (-) [Figure 4]. After that, the patient received 24 Gy CSI with a 16 Gy boost to the temporal region.
The 1-month (a), 6-month (b), and 1-year (c) postoperative MRI showed no tumor remnant.
SNI-12-549-g005.jpg
PMC8645499_01_SNI-12-549-g005.jpg
F5
The 1-year postoperative MRI showed no tumor remnant [Figure 5].